Please be aware that some of the information / intended uses / configurations / accessories mentioned here are not available in your country. For more information contact your local distributor.
In Australia:
EMSCULPT NEO is intended for treatment of obesity by fat reduction through neuromuscular stimulation, radiofrequency induced lipolysis and increase of the blood flow. BTL EMSCULPT is intended for treatment of obesity by fat reduction through neuromuscular stimulation and increase of the blood flow.BTL EMSCULPT is intended to be used for waist circumference reduction and muscle strengthening. The device is used for application of high-intensity electromagnetic energy for body reshaping and fat reduction. BTL EMSELLA is intended to provide pelvic floor muscle strengthening for treatment of genitourinary system diseases/disorders such as urinary incontinence, urinary incontinence after radical prostatectomy, female sexual dysfunction, erectile dysfunction, postpartum pelvic floor dysfunction and pelvic pain syndrome in male and female patients.The Exilis Ultra 360 is intended for fat and wrinkles reduction. Vanquish / BTL Vanquish ME is indicated for fat reduction and for reduction in circumference. EMTONE is intended to skin tightening, fat reduction and reduction of cellulite. BTL-6000 X-Wave Optimal is used for application of shockwave energy into the tissue decreases pain sensations and supports local microcirculation what results in local metabolism enhancement. The device uses the ballistic principle of the shockwave generation. The shock wave is formed via a projectile by accelerated compressed air, which is generated by an electronically controlled air-compressor. The kinetic energy of the projectile is transferred into a probe of the applicator and subsequently into the client's body. *Data on file.
1Abdominal toning and reduction of subcutaneous fat with combination of novel radiofrequency treatment and HIFEM procedure - MRI scan study. Jacob C. et al. Presented at ASDS 2020 Virtual Meeting.
2Radiofrequency heating and HIFEM delivered simultaneously - the first shamcontrolled randomized trial. Katz B. et al. Presented at ASDS 2020 Virtual Meeting.
3Ultrasound evaluation of the simultaneous RF and HIFEM treatments on human fat tissue. Denkova R. Source: U.S. Food and Drug Administration. 510(k) Premarket Notification: K192224. Published online on December 5, 2019.
Results and patient experience may vary. As with any medical procedure, ask your doctor if the procedure is right for you.
This site is not intended for US customers. US customers, click here.
We are protecting our clients‘ personal data responsibly. Read more.
© 2020, BTL Group of Companies. All rights reserved. | sales@btlnet.com | Sitemap |
Terms of Use
| Privacy Statement
| GDPR
